Oxford, United Kingdom

Hui Wang

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Natural Environment Research Council. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hui Wang. Retrieved from https://idiyas.com/inventor/hui-wang-0r2l4qzp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hui Wang - Innovator in Allergy Treatment

Introduction

Hui Wang is a notable inventor based in Oxford, GB. He has made significant contributions to the field of allergy treatment through his innovative research and development. His work focuses on methods and materials for treating conditions associated with IgE activation in humans and animals.

Latest Patents

Hui Wang holds a patent for "Methods of administering IGBPMA to treat type 1 hypersensitivity." This invention relates to agents capable of modulating IgE activation, specifically utilizing IGBPMA polypeptides derived from ticks. This advancement has the potential to improve treatment options for individuals suffering from allergic reactions.

Career Highlights

Hui Wang is affiliated with the Natural Environment Research Council, where he conducts research aimed at understanding and treating allergic conditions. His work is characterized by a commitment to scientific excellence and innovation.

Collaborations

Hui Wang collaborates with Patricia Anne Nuttall, who is also involved in research related to allergy treatment. Their partnership exemplifies the importance of teamwork in advancing scientific knowledge and developing effective treatments.

Conclusion

Hui Wang's contributions to allergy treatment through his patent and research at the Natural Environment Research Council highlight his role as an innovator in the field. His work continues to pave the way for new therapeutic approaches to managing allergic conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…